Prognostic value of DNA ploidy in prostatic cancer;Valor pronóstico de la ploidía del ADN en el cáncer de próstata

Actas urologicas españolas

Volumn 25, Issue 4, 2001, Pages 283-290

  Martinez Jabaloyas J M ^a   Ruiz Cerda J L ^a   Sanz Chinesta, S ^a   Jimenez A ^a   Hernandez M ^a   Jimenez Cruz J F ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADENOCARCINOMA; AGED; ARTICLE; CHEMISTRY; GENETICS; HUMAN; MALE; MIDDLE AGED; PLOIDY; PROGNOSIS; PROSTATE TUMOR; RETROSPECTIVE STUDY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; DNA, NEOPLASM; HUMANS; MALE; MIDDLE AGED; PLOIDIES; PROGNOSIS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 0035317751     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-4806(01)72616-2     Document Type: Article

References (35)

1. P. Boyle P. Maisonneuve P. Napalkov Geographical and temporal patterns of incidenc and mortality from prostate cancer Urology 46 Suppl A 1995 47 55
2. R.V.P. Hutter J.E. Montie C. Busch D.J. Grignon M. Lieber C. Logothetis H. Ragde V.E. Reuter Current prognostic factors and their relevance to staging Cancer 78 1996 369 371
3. M.M. Lieber Practical clinical utility of DNA ploidy for managing patients with prostate carcinoma Urology 45 1995 558 562
4. T.A. Stamey DNA ploidy status Urology 45 1995 563 565
5. L.H. Sobin C.H. Wittekind UICC: TNM Classification of Malignant Tumours, 5th edn 1997 Wiley-Liss, Inc New York
6. W.D. Hedley M.L. Friedlander I.W. Taylor C.A. Rugg E.A. Musgrove Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry J Histochem Cytochem 31 1983 1.333 1.335
7. M.S. Soloway The importance of prognostic factors in advanced prostate cancer Cancer 66 1990 1.017 1.021
8. P.F.A. Mulders G.A. Dijkman P. Fernández del moral A.G.M. Theeuwes F.M.L. Debruyne Members of the Dutch Southeastern Urological Cooperative Group: Analysis of prognostic factors in disseminated prostatic cancer Cancer 65 1990 2.758 2.761
9. D.S. Ernst J. Hanson P.M. Venner Analysis of prognostic factors in men with metastatic prostate cancer. Uro-oncology Group of Northern Alberta J Urol 146 1991 372 376
10. M. Arrizabalaga Moreno J.I. García gonzález M. Mora durván J.M. Díez rodríguez R. Esteban artiaga J. Navarro sebastián M. Castro pita P. Paniagua andrés Evolución y factores pronósticos de los adenocarcinomas de próstata metastasicos al diagnóstico Actas Urol Esp 21 1997 724 736
11. J.M. Wilson I.W. Kemp G.J. Stein Cancer of the prostate. Do younger men have a poorer survival rate? Br J Urol 56 1984 391 396
12. H. Grönberg J.E. Damber H. Jonsson P. Lenner Patient age as a prognostic factor in prostate cancer J Urol 152 1994 892 895
13. A. Krongrad H. Lai S.H. Lamm S. Lai Mortality in prostate cancer J Urol 156 1996 1.084 1.091
14. W.J. Catalona S. Bigg Nerve-sparing radical prostatectomy: evaluation of results after 250 patients J Urol 143 1990 538
15. P. Leandri G. Rossignol J.R. Gautier J. Ramon Radical retropubic prostatectomy: morbidity and quality of life. Experience with 620 consecutive cases J Urol 147 1992 883 887
16. A.S. Tavares J. Costa A. De carvalho M. Reis Tumor ploidy and prognosis in carcinomas of the bladder and prostate Brit J Cancer 20 1966 438 441
17. M.V.P. Fordham A.H. Burdget J. Matthews G. Williams T. Cooke Prostatic carcinoma cell DNA content measured by flow cytometry and its relation to clinical outcome Br J Surg 73 1986 400 403
18. B. Tribukait Flow cytometry in assessing the clinical aggressiveness of genito-urinary neoplasms World J Urol 5 1987 108 122
19. O. Nativ H.Z. Winkler Y. Raz T.M. Therneau G.M. Farrow R.P. Myers H. Zincke M.M. Lieber Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis Mayo Clin Proc 64 1989 911 919
20. B.T. Montgomery O. Nativ M.L. Blute G.M. Farrow R.P. Myers H. Zincke T.M. Therneau M.M. Lieber Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy Arch Surg 125 1990 327 331
21. J. Miller D.J. Horsfall V.R. Marshall D.M. Rao S.Y. Leong The prognostic value of deoxyribonucleic acid flow cytometric analysis in stage D2 prostatic carcinoma J Urol 145 1991 1.192 1.196
22. R. Nagel H. Al abadi The prognostic significance of ploidy and DNA-heterogeneity in the primary diagnosis and monitoring of patients with locally advanced prostatic carcinoma Scand J Urol Nephrol Suppl 138 1991 83 92
23. T. Visakorpi O.P. Kallioniemi I.Y. Paronen J.J. Isola A.I. Heikkinen T.A. Koivula Flow cytometric analysis of DNA ploidy and S-phase fraction from prostatic carcinomas: implications for prognosis and response to endocrine therapy Br J Cancer 64 1991 578 582
24. F. Di silverio G. D’Eramo M. Caponera F. Persechino P. Eleuteri D. Cavallo R. De vita D. Forte The prognostic value of DNA content in patients with prostatic carcinoma Eur Urol 21 suppl 1992 92 95
25. G. Forsslund P. Esposti B. Nilsson A. Zetterberg The prognostic significance of nuclear DNA content in prostatic carcinoma Cancer 69 1992 1.432 1.439
26. J. Song W.S. Cheng R.E. Cupps J.D. Earle G.M. Farrow M.M. Lieber Nuclear deoxyribonucleic acid content measured by static cytometry: important prognostic association for patients with clinically localized prostate carcinoma treated by external beam radiotherapy J Urol 147 1992 794 797
27. H. Zincke E.J. Bergstralh J.J. Larson-keller G.M. Farrow R.P. Myers M.M. Lieber D.M. Barrett R.P. Rife N.F. Gonchoroff Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patientes with DNA diploid Tumors Cancer 70 1 Suppl 1992 311 323
28. N. Tinari C. Natoli D. Angelucci R. Tenaglia B. Fiorentino P. Di stefano C. Amatetti A. Zezza M. Nicolai S. Iacobelli DNA and Sphase fraction analysis by flow cytometry in prostate cancer. Clinicopathologic implications Cancer 71 1993 1.289 1.296
29. B. Tribukait Nuclear deoxyribonucleic acid determinaction in patients with prostate carcinomas: clinical research and application Eur Urol 23 2 1993 64 76
30. A. Pollack G.K. Zagars A.K. El naggar N.H. Terry Relationship of tumor DNA-ploidy to serum prostate-specific antigen doubling time after radiotherapy for prostate cancer Urology 44 1994 711 718
31. M. Borre M. Hoyer B. Nerstrom J. Overgaard DNA ploidy and survival of patients with clinically localized prostate cancer treated without intent to cure Prostate 36 1998 244 249
32. L.G. Koss B. Czerniak F. Herz R.P. Wersto Flow cytometric measurements of DNA and other cell components in human tumors: a critical appraisal Hum Pathol 20 1989 528 548
33. M. Eskelinen P. Lipponen R. Majapuro K. Syrjanen S. Nordling DNA ploidy, S phase fraction and G2 fraction as prognostic determinants in prostatic adenocarcinoma Eur Urol 20 1991 62 66
34. B.A. Centeno A.L. Zietman W.U. Shipley M.L. Sobczak J.W. Shipley F.I. Preffer B.J. Boyle R.B. Colvin Flow cytometric analysis of DNA ploidy, percent S-phase fraction, and total proliferative fraction as prognostic indicators of local control and survival following radiation therapy for prostate carcinoma Int J Radiat Oncol Biol Phys 30 1994 309 315
35. S. Vesalainen S. Nordling P. Lipponen M. Talja K. Syrjanen Progression and survival in porstatic adenocarcinoma a comparision of clinical stage, Gleason grade, S-phase fraction an DNA ploidy Br J Cancer 70 1994 309 314